Skip to content
Clinical Trials – home

SYNEXUS Magyarorszag Kft.

Verified siteinfo

Hungary Becsi Ut 61, 1036 Budapest, Hungary

  • Chronic obstructive pulmonary disease · Colitis ulcerative · Dermatitis atopic
  • Adults and children

About Specializations

SYNEXUS Magyarorszag Kft. in Budapest, Hungary specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Colitis ulcerative, Dermatitis atopic, Diabetic neuropathy, and other specialisations. This site conducts important research.

Main research areas of the site

Metabolic and Cardiovascular Research

At SYNEXUS Magyarorszag Kft. in Budapest, clinical trials in Nutritional and Metabolic Diseases focus on type 2 diabetes mellitus, obesity, and chronic weight management. These studies are designed to evaluate new treatments for glucose control, body weight reduction, and broader cardiovascular safety.

  • Testing new therapy options for type 2 diabetes mellitus
  • Evaluating treatment approaches for obesity and chronic weight management
  • Assessing cardiovascular safety in people with excess weight

This area reflects a strong interest in improving long-term care for common metabolic conditions that often overlap with one another.

Gastroenterology and Inflammatory Bowel Disease

The site also supports research in Digestive System Diseases, with trials in Crohn’s disease and ulcerative colitis. These studies aim to improve symptom control, increase remission rates, and better understand the safety and effectiveness of newer immune-based therapies.

  • Studying treatment effectiveness in Crohn’s disease
  • Evaluating remission in ulcerative colitis
  • Exploring improved options for inflammatory bowel disease

This research helps advance care for patients living with chronic intestinal inflammation and related digestive disorders.

Dermatology and Immune-Mediated Skin Disease

Clinical trials in Skin and Connective Tissue Diseases and Immune System Diseases include atopic dermatitis and moderate-to-severe plaque psoriasis. The main purpose is to test therapies that may reduce inflammation, improve skin symptoms, and support longer-term disease control.

  • Investigating treatment options for atopic dermatitis
  • Assessing long-term management of plaque psoriasis
  • Improving control of chronic immune-mediated skin disease

The work in this field highlights a continued effort to find more effective and durable approaches for inflammatory skin conditions.

Rheumatology and Musculoskeletal Conditions

Research in Musculoskeletal Diseases at the site includes rheumatoid arthritis, psoriatic arthritis, and knee osteoarthritis. These trials are focused on reducing pain, improving joint function, and evaluating whether newer therapies can better control chronic inflammatory and degenerative joint disease.

  • Studying symptom relief in rheumatoid arthritis
  • Evaluating disease control in psoriatic arthritis
  • Testing pain reduction strategies for knee osteoarthritis

This area combines inflammatory and structural joint disorders, offering insights into both comfort and long-term mobility.

Respiratory and Chronic Lung Disease Research

The site’s Respiratory Tract Diseases portfolio includes chronic obstructive pulmonary disease. Trials in this area are aimed at reducing flare-ups, improving daily breathing, and assessing the effectiveness of add-on treatment strategies for people with persistent lung symptoms.

  • Evaluating care for chronic obstructive pulmonary disease
  • Reducing exacerbations in chronic lung disease
  • Improving symptom control in respiratory disease

This research supports better management of a common long-term lung condition that can significantly affect quality of life.

Neurology and Pain Management

In Nervous System Diseases, the trials focus on chronic pain due to diabetic peripheral neuropathy. The goal is to evaluate whether new treatments can provide better pain relief and improve daily functioning for people affected by nerve-related complications of diabetes.

  • Studying pain relief in diabetic peripheral neuropathy
  • Assessing therapies for chronic nerve pain
  • Improving quality of life in neuropathic pain

This field addresses an important unmet need for patients living with persistent, diabetes-related nerve pain.

Broader Inflammatory and Immune Research

Across several therapeutic areas, the Hungary-based site is also involved in studies that examine how targeted therapies perform in chronic inflammatory disease. These trials aim to improve the understanding of treatment benefit, safety, and durability across multiple conditions.

  • Supporting research in immune-mediated disease
  • Comparing newer therapies with standard care
  • Exploring longer-term disease control in chronic conditions

With 14 trials and 14 investigators, the site shows a broad and active commitment to clinical research across metabolic, digestive, skin, joint, respiratory, and nerve-related diseases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Becsi Ut 611036 BudapestHungary
Recruiting now
no trials
Conditions studied
15
Partner status
Verified site

More sites in BudapestHungary

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

15 clinical trials

Osteoporosis postmenopausal

Not yet recruiting

Study on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Curateq Biologics Private Limited

Obesity

Not recruiting

Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim Espana S.A.

Psoriatic arthropathy

Not recruiting

Study on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Psoriasis

Not recruiting

Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Rheumatoid arthritis

Not recruiting

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Dr Reddy's Laboratories Limited

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Neuralgia

Not recruiting

Study on the Effectiveness and Safety of NT 201 Injections for Adults with Chronic Neuropathic Pain from Postherpetic Neuralgia or Nerve Injury

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Paracetamol
  • Sponsor:Merz Therapeutics GmbH

Colitis ulcerative

Not recruiting

Study on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Vedolizumab
  • Sponsor:Polpharma Biologics S.A.

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

Osteoarthritis

Not recruiting

Study on the Effects of DFV890 for Pain Relief in Patients with Knee Osteoarthritis

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:DFV890
  • Sponsor:Novartis Pharma AG
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.